Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07179601 · ClinicalTrials.gov registry record · NA
Hemorrhoidal Artery Embolization: Longitudinal Impact On Symptoms (HELIOS)
A NA study of HAE and Internal Hemorrhoids, sponsored by University of California, Los Angeles.
- Recruiting
- Registry status
- NA
- Development phase
- 22
- Enrollment target
- 1
- Study location
NCT07179601 is a NA study of HAE and Internal Hemorrhoids that is actively recruiting participants, run by University of California, Los Angeles. The registered enrollment target is 22 participants. The trial reports 1 study location across 1 state.
The verdict
NCT07179601, a NA study of HAE and Internal Hemorrhoids, is actively recruiting participants, sponsored by University of California, Los Angeles.
- RECRUITING
- Registry status
- NA
- Development phase
- 22 participants
- Enrollment target
- 1
- Study location
Study Summary
Hemorrhoidal artery embolization (HAE) is a novel treatment for symptomatic internal hemorrhoids. HAE involves the deliberate blockage (embolization) of enlarged rectal or hemorrhoidal arteries leading to reduction of abnormal blood flow to the hemorrhoidal tissue. The aim of HAE is to the improve hemorrhoid related symptoms, especially bleeding. Initial reports of HAE have demonstrated that it both safe and effective. Following an initial clinic visit to determine trial candidacy, enrolled patients will be subsequently treated with HAE. Patients will be followed for a year with clinic follow-up visits at 1, 3, 6 and 12 months.
Conditions Studied
Interventions
- PROCEDURE Hemorrhoidal artery embolization
Study Locations (1)
California
- University of California, Los Angeles - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2025-08-05 |
| Est. Completion | 2029-09-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07179601
The ClinicalTrials.gov registry entry for NCT07179601 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with HAE appearing as the primary indexed condition, and to 1 intervention - of which Hemorrhoidal artery embolization is the first listed.
NCT07179601 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT07179601 about?
NCT07179601 is a clinical study titled "Hemorrhoidal Artery Embolization: Longitudinal Impact On Symptoms (HELIOS)". Hemorrhoidal artery embolization (HAE) is a novel treatment for symptomatic internal hemorrhoids. HAE involves the deliberate blockage (embolization) of enlarged rectal or hemorrhoidal arteries leading to reduction of abnormal blood flow to the hemorrhoidal tissue. The aim of HAE is to the improve h...
What is the current status of trial NCT07179601?
This trial is currently recruiting. It is a NA study. The enrollment target is 22 participants. The study started on 2025-08-05. Estimated completion is 2029-09-30.
What conditions does trial NCT07179601 study?
This clinical trial studies the following conditions: HAE, Internal Hemorrhoids.
What interventions are being tested in trial NCT07179601?
The interventions under investigation include: Hemorrhoidal artery embolization (PROCEDURE).
Who is sponsoring clinical trial NCT07179601?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07179601 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HAE
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.